Biggest News Aggregation in the World
📰 Recommendation Statement News

Page 16 - Recommendation Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Recommendation Statement. Real-time updates on events, politics, business and more.

F-star Therapeutics, Inc.: F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

- FS118 is Well-Tolerated Across all Dose Levels with No Serious Adverse Events Related to FS118 Therapy - Novel mechanism showing Increased Peripheral Immune Cells and LAG-3 shedding - 54.8%
United States United Kingdom John Fraunces Louis Kayitalire Timothya Yap Sino Biopharmaceutical

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science